UK markets closed

Adamis Pharmaceuticals Corp (CY3.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
2.90000.0000 (0.00%)
At close: 08:36AM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
1,446
4,756
2,209
2,777
Cost of revenue
5,370
6,187
6,872
6,327
Gross profit
-3,924
-1,431
-4,663
-3,550
Operating expenses
Research development
11,716
10,380
11,262
8,040
Selling general and administrative
12,993
13,248
16,144
20,090
Total operating expenses
24,709
23,628
27,406
28,129
Operating income or loss
-28,634
-25,059
-32,069
-31,680
Interest expense
379.392
-
6.649
4.921
Total other income/expenses net
-1,590
-1,183
-2,523
-4,159
Income before tax
-30,608
-26,197
-34,600
-35,844
Income tax expense
0.796
2
0.796
2.4
Income from continuing operations
-30,609
-26,199
-34,600
-35,846
Net income
-31,925
-26,478
-45,828
-49,391
Net income available to common shareholders
-31,925
-26,478
-45,828
-49,391
Basic EPS
-6.60
-12.60
-22.40
-44.80
Diluted EPS
-6.60
-12.60
-22.40
-44.80
Basic average shares
3,504
2,141
2,059
1,108
Diluted average shares
3,504
2,141
2,059
1,108